Methylphenidate and Parkinson's Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this trial is to determine if methylphenidate (MPD), a drug marketed in the U.S. to treat hyperactivity and narcolepsy, added to levodopa, will increase the beneficial effects of levodopa without bothersome side effects in people with Parkinson\'s disease (PD).
Epistemonikos ID: 483b6680e54b04c69c88ef07345747db5f6d5258
First added on: May 04, 2024